SALT LAKE CITY, Utah, March 12, 2026 (Bills Marketplace/Gephardt Daily) A major shift is underway in the weight-loss medication market as Wegovy becomes the first pill form of semaglutide available in the United States
Clinical observations suggest: Some patients report heartburn or acid regurgitation symptoms after starting tirzepatide Individuals with pre-existing reflux symptoms may experience exacerbation Symptoms appear more common during initial treatment phases and dose escalation Symptoms may correlate with larger meal sizes or lying down shortly after eating The exact frequency of reflux symptoms varies by indication, dose, and individual patient factors
Food and Drug Administration for safety, efficacy, diagnosis, treatment, cure, or prevention of any disease or condition
Ozempic (semaglutide) is the most widely recognized GLP-1 receptor agonist
Berberine tends to work relatively quickly, with some people noticing improvements in blood sugar regulation within a few weeks